Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × Diet × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 10 Motor Activity 5 Weight Loss 2 Carcinoma, Intraductal, Noninfiltrating 2 Triple Negative Breast Neoplasms 1 Recurrence 1 Prostatic Neoplasms 1 Obesity 1 Colorectal Neoplasms 1 Breast Carcinoma In Situ 1 Breast Cancer Female 1 Body Weight Changes 1

Interventions

Cyclophosphamide 6 Radiotherapy 5 olaparib 3 Paclitaxel 3 Letrozole 3 Itraconazole 3 Carboplatin 3 Blood Specimen Collection 3 palbociclib 2 fludarabine phosphate 2 exemestane 2 eribulin 2 avelumab 2 abemaciclib 2 Therapeutics 2 Polymerase Chain Reaction 2 Peripheral Blood Stem Cell Transplantation 2 Melphalan 2 Mastectomy 2 Gemcitabine 2 Fulvestrant 2 Flow Cytometry 2 Exercise 2 Etoposide 2 Cetuximab 2 Carmustine 2 Bevacizumab 2 Antilymphocyte Serum 2 Anastrozole 2 Amplified Fragment Length Polymorphism Analysis 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02035631 2014-01-14

PREDICOP

Institut Català d'Oncologia

Phase 3 Unknown

Breast Neoplasms, Motor Activity, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡